JP2010526082A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526082A5
JP2010526082A5 JP2010506582A JP2010506582A JP2010526082A5 JP 2010526082 A5 JP2010526082 A5 JP 2010526082A5 JP 2010506582 A JP2010506582 A JP 2010506582A JP 2010506582 A JP2010506582 A JP 2010506582A JP 2010526082 A5 JP2010526082 A5 JP 2010526082A5
Authority
JP
Japan
Prior art keywords
formulation
amino acid
hydroxide
transfer agent
phase transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010506582A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526082A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/061942 external-priority patent/WO2008134687A1/en
Publication of JP2010526082A publication Critical patent/JP2010526082A/ja
Publication of JP2010526082A5 publication Critical patent/JP2010526082A5/ja
Withdrawn legal-status Critical Current

Links

JP2010506582A 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物 Withdrawn JP2010526082A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91529107P 2007-05-01 2007-05-01
PCT/US2008/061942 WO2008134687A1 (en) 2007-05-01 2008-04-30 N-halogenated amino acid formulations

Publications (2)

Publication Number Publication Date
JP2010526082A JP2010526082A (ja) 2010-07-29
JP2010526082A5 true JP2010526082A5 (cg-RX-API-DMAC7.html) 2011-06-02

Family

ID=39596568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506582A Withdrawn JP2010526082A (ja) 2007-05-01 2008-04-30 N−ハロゲン化アミノ酸処方物

Country Status (16)

Country Link
US (1) US20080275123A1 (cg-RX-API-DMAC7.html)
EP (1) EP2139518A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010526082A (cg-RX-API-DMAC7.html)
KR (1) KR20100017166A (cg-RX-API-DMAC7.html)
CN (1) CN101674849A (cg-RX-API-DMAC7.html)
AR (1) AR066373A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008245455A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0810790A2 (cg-RX-API-DMAC7.html)
CA (1) CA2684098A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008001279A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009011819A (cg-RX-API-DMAC7.html)
RU (1) RU2009144292A (cg-RX-API-DMAC7.html)
TW (1) TW200902093A (cg-RX-API-DMAC7.html)
UY (1) UY31059A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008134687A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200907050B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31058A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
JP2011516578A (ja) * 2008-04-10 2011-05-26 ノバベイ・ファーマシューティカルズ・インコーポレイテッド 気管支肺感染症の治療および予防のための組成物および方法
CA2723262A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
US20100076089A1 (en) * 2008-08-12 2010-03-25 Novabay Pharmaceuticals, Inc. Antimicrobial gel formulations
WO2010091280A1 (en) * 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
CN102625558B (zh) * 2012-03-30 2014-09-03 安徽航天环境工程有限公司 带有冷却系统的等离子体加热器

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92351A (en) * 1988-11-29 1994-02-27 Allergan Inc Irvine Aqueous opthalmic solutions containing stabilized chlorine dioxide and an inorganic salt
US5320805A (en) * 1991-05-15 1994-06-14 Sterilex Corporation Methods of using a cleaner, sanitizer, disinfectant, fungicide, sporicide, chemical sterilizer
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US5968986A (en) * 1997-12-18 1999-10-19 Woodward Laboratories, Inc. Antimicrobial nail coating composition
US6759434B2 (en) * 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
DK1656095T3 (en) * 2003-08-18 2014-03-10 Novabay Pharmaceuticals Inc N, N-DIHALOGENG-GENERATED AMINO ACIDS AND DERIVATIVES
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法

Similar Documents

Publication Publication Date Title
TWI626006B (zh) 抗微生物組成物
KR101057609B1 (ko) N,n-디할로겐화 아미노산 및 유도체
JP2010526082A5 (cg-RX-API-DMAC7.html)
US7976875B2 (en) Biofilm extracellular polysaccharide solvating system
JP4848484B2 (ja) ケイ素含有化合物を含む抗菌剤組成物、並びに抗菌化方法、洗浄・洗口方法及び抗菌剤固定化方法
JP2009536666A5 (cg-RX-API-DMAC7.html)
CN1798581A (zh) 感染朊病毒的材料污染表面的清洁和去污染制剂
JP2008531479A5 (cg-RX-API-DMAC7.html)
JP2003530447A5 (cg-RX-API-DMAC7.html)
US9451777B2 (en) Cleaning and sanitizing with antibacterial film
JP2010525886A5 (cg-RX-API-DMAC7.html)
KR101553431B1 (ko) 필터링 효과를 증가시키기 위한 정전기적으로 전하를 띠는 마스크 필터 생성물 및 제조방법
RU2009144292A (ru) Препараты n-галогенированных аминокислот
CN111557938A (zh) 一种快速损伤病毒囊膜的消毒制剂
JP2010526085A5 (cg-RX-API-DMAC7.html)
JP6783516B2 (ja) カリシウイルス不活化効果を有する組成物
JP2010526084A5 (cg-RX-API-DMAC7.html)
CA3023037A1 (en) Anti-microbial compositions comprising quaternary organosilane compounds
TW202145995A (zh) 殺菌或殺病毒用之皮膚外用劑組合物
WO2021038529A1 (en) Treatment and prophylaxis of viral infections
WO2010091280A1 (en) N-halogenated amino acid formulations comprising phosphine or amine oxides
US20230151302A1 (en) Cationic surfactants, in particular ethyl lauroyl arginate LAE, for treating or preventing infections and contaminations with Coronavirus
RU2009144291A (ru) Лекарственные средства n-галогенированных аминокислот, содержащие алифатическую кислоту
CN108834403B (zh) 消毒组合物
WO2023190598A1 (ja) 組成物